The Nigerian clinical laboratory services market is expected to register around a CAGR of 5.5% during the forecast period.
The market studied is primarily driven by the rising incidences of chronic diseases and the increasing demand for accurate disease diagnosis, along with the government’s focus on public-private partnerships. However, the lack of medical laboratories, advanced diagnostic equipment, and inadequately trained laboratory staff are restraining the market’s growth. Nigeria is one of the developing countries that is facing double burden disease, i.e., the persisting high prevalence of communicable diseases, along with the rising prevalence of non-communicable diseases. According to the WHO report, 2016, deaths from infectious diseases, maternal and perinatal conditions, and nutritional deficiencies combined may increase by 6%, deaths from chronic diseases are expected to increase by 24%, and distinctly, deaths from diabetes are anticipated to increase by 52%. WHO estimated that a 2% annual reduction in chronic disease death rates in Nigeria may result in an economic gain of USD 500 million for the country, over the next 10 years. The progression of chronic diseases can be prevented through lifestyle changes. However, the early diagnosis of an underlying disease is necessary for interventions to be effective. Thus, owing to the increasing burden of chronic diseases, the volumes of diagnostic tests are expected to increase rapidly, resulting in the expansion of the market.
Key Market Trends
The Independent and Reference Laboratories Segment, by Provider, is Expected to Hold the Largest Market Share
The independent and reference laboratories segment of the Nigerian clinical laboratory services market is believed to have the largest market size, and it is expected to witness a CAGR of 5.76% over the forecast period.
The demand for laboratory testing is increasing, due to the increasing incidences of chronic diseases, thereby increasing the demand for the accurate diagnosis of different diseases. Nigeria is a highly populated country where a significant chunk of the population does not have access to medical diagnostic facilities. In Nigeria, the laboratory services are integrated with the three-tier public health system at the primary, secondary, and tertiary levels. Additionally, there are reference laboratories, research laboratories, and disease-specific reference laboratories to provide services for complex and special tests. With the COVID-19 cases rising, there is huge scope for an increase in the independent laboratories in the region. According to a report by hrw.org, published on March 24th, there was a sharp rise in the cases of COVID-19 from 8 to 44 within a week.
The Nigerian health plans of the past were created in such a way that medical professionals, other than doctors, did not have direct contact with the patients. This made it difficult for the public to understand the responsibility of other lab professionals, thus causing exploitation and unethical lab practices. To perform any laboratory test, a skilled professional is required to collect and analyze the samples and aid in the diagnosis of different diseases. However, insufficient funding from government and scarcity of trained professionals are anticipated to restrict the growth of the market studied, over the forecast period.
The market concentration of the Nigerian clinical laboratory services market is high, and some major players are currently dominating the market. These major players include Mecure Healthcare Limited, Union Diagnostic and Clinical Services PLC, Echo-Scan Services Limited, and Synlab Bondco PLC. However, there are some mid-sized companies that are focusing on market penetration, and they are expected to hold a substantial share in the market during the forecast period.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support